RT Journal Article
SR Electronic
T1 Passively Sensing SARS-CoV-2 RNA in Public Transit Buses
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.02.21258184
DO 10.1101/2021.06.02.21258184
A1 Hoffman, Jason
A1 Hirano, Matthew
A1 Panpradist, Nuttada
A1 Breda, Joseph
A1 Ruth, Parker
A1 Xu, Yuanyi
A1 Lester, Jonathan
A1 Nguyen, Bichlien
A1 Ceze, Luis
A1 Patel, Shwetak N.
YR 2021
UL http://medrxiv.org/content/early/2021/06/04/2021.06.02.21258184.abstract
AB Affordably tracking the transmission of respiratory infectious diseases in urban transport infrastructures can inform individuals about potential exposure to diseases and guide public policymakers to prepare timely responses based on geographical transmission in different areas in the city. Towards that end, we designed and tested a method to detect SARS-CoV-2 RNA in the air filters of public buses, revealing that air filters could be used as passive fabric sensors for the detection of viral presence. We placed and retrieved filters in the existing HVAC systems of public buses to test for the presence of trapped SARS-CoV-2 RNA using phenol-chloroform extraction and RT-qPCR. SARS-CoV-2 RNA was detected in 14% (5/37) of public bus filters tested in Seattle, Washington, from August 2020 to March 2021. These results indicate that this sensing system is feasible and that, if scaled, this method could provide a unique lens into the geographically relevant transmission of SARS-CoV-2 through public transit rider vectors, pooling samples of riders over time in a passive manner without installing any additional systems on transit vehicles.Synopsis Passive sensing of viral presence on urban transit infrastructure is proven, with forward-looking benefits for tracking pandemic spread.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the University of Washington Population Health Department for the Economic Recovery grant and the Microsoft Studies in Pandemic Preparedness and AI for Health programs.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB approval, as this was an environmental study involving no study participants.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is shared in Supplemental Information and will be provided via Github shortly.